The Oslo Acute Reperfusion Stroke Study (OSCAR)

Launched by OSLO UNIVERSITY HOSPITAL · Jan 23, 2024

Keywords

ClinConnect Summary

The Oslo Acute Reperfusion Stroke Study (OSCAR) is a clinical trial designed to gather information about patients who have had an acute ischemic stroke, which occurs when a blood vessel in the brain gets blocked, preventing blood flow. This study is specifically looking at patients who have undergone a treatment called endovascular revascularization, a procedure to restore blood flow to the brain. The goal of the trial is to collect both clinical (medical) and radiological (imaging) data to better understand the outcomes of this treatment in stroke patients.

To participate in this study, individuals must be at least 18 years old and have experienced an ischemic stroke treated with the endovascular procedure. The study welcomes patients of all ages and stroke severity levels. Before joining, participants or their family members will need to provide informed consent, meaning they understand the study and agree to take part. Those who are unable to give consent or are not available for follow-up will not be included in the study but will still receive standard care for their condition. Participants can expect to be part of a registry that helps improve knowledge and treatment options for future stroke patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years or older
• • Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization.
• • All stroke severities and vascular distributions are eligible.
• • Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.
• Exclusion criteria:
• • • Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).